| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |